In consistence with the findings about FOXN3 mRNA expression, Western blotting analysis showed that FOXN3 protein was notably under-expressed in glioma tissues in comparison with normal brain tissues (Figure 1B, P < 0.01). The gene discussed is FOXN3; the disease is central nervous system cancer.